Longer Patents for Lower Imitation Barriers: The 1984 Drug Act
Abstract
In this paper we analyze its likely impacts on competition in the pharmaceutical industry,
the incentives for innovation, and general consumer welfare.
Type
Journal articlePermalink
https://hdl.handle.net/10161/1848Collections
More Info
Show full item recordScholars@Duke
Henry G. Grabowski
Professor Emeritus of Economics
Professor Grabowski specializes in the investigation of economics in the pharmaceutical
industry, government regulation of business, and the economics of innovation. His
specific interests within these fields include intellectual property and generic competition
issues, the effects of government policy actions, and the costs and returns to pharmaceutical
R&D. He has been publishing research papers for over four decades, from his earlier
work, “The Effects of Regulatory Policy on the Incentives
Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles